Exagen to Announce First Quarter 2024 Results on May 13, 2024 - Exagen (NASDAQ:XGN)
CARLSBAD, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (NASDAQ:XGN), a leading provider of autoimmune testing, will release financial results for the quarter ended March 31, 2024, before the market opens on